Epstein-Barr Virus Associated Lymphoma
1 competing product in clinical development for Epstein-Barr Virus Associated Lymphoma.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Nanatinostat in combination with valganciclovir | Viracta Therapeutics | Phase 2 | Terminated | 44 |